Abdominal Ultrasound Examination Findings in 534 Hyperthyroid Cats Referred for Radioiodine Treatment Between 2007–2010

E-ISSN： 1939-1676|29|4|1069-1073

ISSN： 0891-6640

Source： Journal Of Veterinary Internal Medicine, Vol.29, Iss.4, 2015-07, pp. : 1069-1073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

BackgroundThe prevalence of concurrent disease in hyperthyroid cats is unknown.ObjectivesTo identify the prevalence of concurrent intra‐abdominal disease using abdominal ultrasound examination (AUS) in hyperthyroid cats referred for radioactive iodine treatment (RIT) and to determine whether the requirement for pretreatment AUS is justified.AnimalsFive hundred and thirty‐four client‐owned cats diagnosed with hyperthyroidism and referred for RIT.MethodsRetrospective study. Age, breed, sex, body weight, clinical signs, total serum T4 concentration, blood urea nitrogen (BUN) concentration, serum creatinine concentration, urine specific gravity (USG), AUS results, and biopsy or cytology results, or both (if obtained) were collected from the medical records.ResultsThe prevalence of concurrent disease identified using AUS in hyperthyroid cats referred for RIT was 36.1%; 22.8% of the cats in the study had renal disease and 2.4% had confirmed neoplasia. Significant differences in median USG (P value 0.032) and median BUN (P value 0.028) were found between cats that had abnormal kidneys on AUS compared to those with normal‐appearing kidneys. Only 2.2% of the cats were not treated with RIT as a result of changes identified on AUS and subsequently obtained cytology or biopsy results.Conclusions and Clinical ImportanceThe results indicate that pretreatment AUS in hyperthyroid cats referred for RIT is unnecessary in most patients.